182 related articles for article (PubMed ID: 31160676)
1. Relationship between ETS Transcription Factor ETV1 and TGF-β-regulated SMAD Proteins in Prostate Cancer.
Oh S; Shin S; Song H; Grande JP; Janknecht R
Sci Rep; 2019 Jun; 9(1):8186. PubMed ID: 31160676
[TBL] [Abstract][Full Text] [Related]
2. Induction of prostatic intraepithelial neoplasia and modulation of androgen receptor by ETS variant 1/ETS-related protein 81.
Shin S; Kim TD; Jin F; van Deursen JM; Dehm SM; Tindall DJ; Grande JP; Munz JM; Vasmatzis G; Janknecht R
Cancer Res; 2009 Oct; 69(20):8102-10. PubMed ID: 19789348
[TBL] [Abstract][Full Text] [Related]
3. Interaction of the Androgen Receptor, ETV1, and PTEN Pathways in Mouse Prostate Varies with Pathological Stage and Predicts Cancer Progression.
Higgins J; Brogley M; Palanisamy N; Mehra R; Ittmann MM; Li JZ; Tomlins SA; Robins DM
Horm Cancer; 2015 Jun; 6(2-3):67-86. PubMed ID: 25631336
[TBL] [Abstract][Full Text] [Related]
4. BZW1 promotes cell proliferation in prostate cancer by regulating TGF-β1/Smad pathway.
Shi Z; Xiao C; Lin T; Wu J; Li K
Cell Cycle; 2021 May; 20(9):894-902. PubMed ID: 33886419
[TBL] [Abstract][Full Text] [Related]
5. 14-3-3 proteins modulate the ETS transcription factor ETV1 in prostate cancer.
Oh S; Shin S; Lightfoot SA; Janknecht R
Cancer Res; 2013 Aug; 73(16):5110-9. PubMed ID: 23774214
[TBL] [Abstract][Full Text] [Related]
6. ETS variant 1 regulates matrix metalloproteinase-7 transcription in LNCaP prostate cancer cells.
Shin S; Oh S; An S; Janknecht R
Oncol Rep; 2013 Jan; 29(1):306-14. PubMed ID: 23076342
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line.
He WX; Niu ZY; Zhao SL; Jin WL; Gao J; Smith AJ
Arch Oral Biol; 2004 Nov; 49(11):911-8. PubMed ID: 15353247
[TBL] [Abstract][Full Text] [Related]
8. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
9. Mitogenic conversion of transforming growth factor-beta1 effect by oncogenic Ha-Ras-induced activation of the mitogen-activated protein kinase signaling pathway in human prostate cancer.
Park BJ; Park JI; Byun DS; Park JH; Chi SG
Cancer Res; 2000 Jun; 60(11):3031-8. PubMed ID: 10850453
[TBL] [Abstract][Full Text] [Related]
10. ETV1 is a novel androgen receptor-regulated gene that mediates prostate cancer cell invasion.
Cai C; Hsieh CL; Omwancha J; Zheng Z; Chen SY; Baert JL; Shemshedini L
Mol Endocrinol; 2007 Aug; 21(8):1835-46. PubMed ID: 17505060
[TBL] [Abstract][Full Text] [Related]
11. Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1.
Kim TD; Jin F; Shin S; Oh S; Lightfoot SA; Grande JP; Johnson AJ; van Deursen JM; Wren JD; Janknecht R
J Clin Invest; 2016 Feb; 126(2):706-20. PubMed ID: 26731476
[TBL] [Abstract][Full Text] [Related]
12. KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression.
Ali A; Zhang P; Liangfang Y; Wenshe S; Wang H; Lin X; Dai Y; Feng XH; Moses R; Wang D; Li X; Xiao J
Cell Death Dis; 2015 Mar; 6(3):e1681. PubMed ID: 25766320
[TBL] [Abstract][Full Text] [Related]
13. ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients.
Baena E; Shao Z; Linn DE; Glass K; Hamblen MJ; Fujiwara Y; Kim J; Nguyen M; Zhang X; Godinho FJ; Bronson RT; Mucci LA; Loda M; Yuan GC; Orkin SH; Li Z
Genes Dev; 2013 Mar; 27(6):683-98. PubMed ID: 23512661
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide analysis of ETV1 targets: Insights into the role of ETV1 in tumor progression.
Eid W; Abdel-Rehim W
J Cell Biochem; 2019 Jun; 120(6):8983-8991. PubMed ID: 30629294
[TBL] [Abstract][Full Text] [Related]
15. COP1 is a tumour suppressor that causes degradation of ETS transcription factors.
Vitari AC; Leong KG; Newton K; Yee C; O'Rourke K; Liu J; Phu L; Vij R; Ferrando R; Couto SS; Mohan S; Pandita A; Hongo JA; Arnott D; Wertz IE; Gao WQ; French DM; Dixit VM
Nature; 2011 May; 474(7351):403-6. PubMed ID: 21572435
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
17. Functions of Smad Transcription Factors in TGF-β1-Induced Selectin Ligand Expression on Murine CD4 Th Cells.
Ebel ME; Kansas GS
J Immunol; 2016 Oct; 197(7):2627-34. PubMed ID: 27543612
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate.
Zeng L; Rowland RG; Lele SM; Kyprianou N
Hum Pathol; 2004 Mar; 35(3):290-7. PubMed ID: 15017584
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of transforming growth factor-beta1-induced signaling and epithelial-to-mesenchymal transition by the Smad-binding peptide aptamer Trx-SARA.
Zhao BM; Hoffmann FM
Mol Biol Cell; 2006 Sep; 17(9):3819-31. PubMed ID: 16775010
[TBL] [Abstract][Full Text] [Related]
20. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
